NCT07733284

Brief Summary

The purpose of this research study is to investigate the effects of a home-based 3-month long walking exercise program on cognitive (thinking) performance in persons with TBI. As a participant, you will complete this 3-month exercise program now or after a 3-month wait period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for early_phase_1

Timeline
4mo left

Started Apr 2026

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Apr 2026Dec 2026

Study Start

First participant enrolled

April 15, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 29, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 22, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

walkingthinkingfitbitexercise

Outcome Measures

Primary Outcomes (3)

  • Adverse Events

    Safety will be primarily measured as adverse events, specifically during the remote walking intervention.

    Through study completion, which is 3 months for intervention and 6 months for wait list.

  • Adherence

    Adherence is measured as the number of exercise sessions attended compared to the number of total sessions prescribed.

    Through study completion, which is 3 months for intervention and 6 months for wait list.

  • Compliance

    Compliance will be measured as the number of exercise sessions completed as prescribed (i.e., intensity and duration).

    Through study completion, which is 3 months for intervention and 6 months for wait list.

Secondary Outcomes (3)

  • Processing Speed

    Baseline and follow-up (12-weeks post-baseline)

  • Learning/Memory

    Baseline and follow-up (12-weeks post-baseline)

  • Executive function

    Baseline and follow-up (12-weeks post-baseline)

Study Arms (2)

Behavioral: Exercise

EXPERIMENTAL

One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

Behavioral: Walking

Wait List

NO INTERVENTION

The other group will stick to a regular routine during this 3-month period (i.e., wait-list group).

Interventions

WalkingBEHAVIORAL

One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

Behavioral: Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Definitive TBI diagnosis at least 1 year prior, verified by medical records
  • Self-report problems with thinking skills since the TBI diagnosis (e.g., processing information, learning or remembering, organizing, multitasking)
  • Between the ages of 18 and 65
  • Access to internet and email
  • Fluent in English
  • Can walk at a brisk pace without using an assistive device
  • Not fallen due to mobility issues from their TBI in the past 6 months
  • Do not currently meet public health guidelines for physical activity
  • Have problems with thinking performance

You may not qualify if:

  • I currently have uncontrolled major depression
  • I have a history of schizophrenia, bipolar disorder I or II, or substance-abuse disorders
  • I am regularly taking medications that can affect my thinking, such as antipsychotics or benzodiazepines. Study staff will review my medications to determine if I am taking any that would make me ineligible for this study
  • I have known/diagnosed cardiovascular disease including uncontrolled hypertension, diabetes, or kidney disease
  • I am unable to make everyday decisions on my own

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

East Hanover, New Jersey, 07936, United States

RECRUITING

MeSH Terms

Conditions

Brain Injuries, TraumaticMotor Activity

Interventions

Walking

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBehavior

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Central Study Contacts

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 22, 2026

First Posted

July 29, 2026

Study Start

April 15, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

We plan to share sample data on safety measures, adherence, and compliance.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
These data will be shared upon completion of data collection (estimated 12/2026) and will be available for three years.
Access Criteria
Interested parties can request data be shared directly form the PI.

Locations